Wharton Alumni Magazine
Fall 2004
Home Archives About Us Connections

Table of Contents

Features

In Good Hands

Credentialism vs Substance

Performance Pays

Departments

Wharton Now

Knowledge@Wharton

Next Up at Wharton School Publishing

Alumni Association Update

Next Up at Wharton School Publishing
www.whartonsp.com

Take advantage of Wharton School Publishing alumni discounts – visit www.whartonsp.com.

Finding Fertile Ground

In a new book from Wharton School Publishing, alumnus Scott Shane, G'92, identifies key factors for success for high-tech startups.

If you're starting a business, your best odds of success are in high technology industries—not just computing and telecom, but also biotech, aerospace, electronics, manufacturing and materials, medical devices, pharmaceuticals, robotics, and other knowledge-intensive fields.

In a new release from Wharton School Publishing entitled Finding Fertile Ground: Identifying Extraordinary Opportunities for New Ventures, Scott Shane, G'92, identifies the drivers behind the world's successful knowledge-intensive startups and offers readers strategies for aligning those drivers behind their own businesses. Along the way, he shows how to account for critical issues such as network externalities, and the emergence of dominant designs and technical standards. In short, Shane's book offers entrepreneurs the tools they need to beat the odds; in fact, David Courtney, Executive Vice President and Board Member of TiVo, Inc., has called the book "a 'must read' for anyone considering starting a new venture."

Shane, who is a professor of economics and entrepreneurship at the Weatherhead School of Management at Case Western Reserve University, has authored over 50 scholarly articles on entrepreneurship. His other books include A General Theory of Entrepreneurship, Foundations of Entrepreneurship, Academic Entrepreneurship, and Wealth Creation and Entrepreneurship. He also edits the Innovation and Entrepreneurship Division of the leading scholarly journal, Management Science. He has taught at MIT's Sloan School of Management, Georgia Tech's DuPree School of Management, and the University of Maryland's Robert H. Smith School of Business.

In the following Q&A, excerpted from Soundview Executive Book Summaries, Shane answers questions about his new book and navigating the high-tech startup field. (The complete interview with Soundview editor-in-chief Chris Murray is available on an audio CD included in Shane's book.)

Q: What is a high-technology venture?

A: These days, when you turn on CNBC or read the Wall Street Journal, and you hear or see the word "technology" to describe something, it is usually in reference to IT companies. This book uses the word "technology" in a broader, more traditional sense. Technology is the embodiment of knowledge in ways that make it possible to create new products, exploit new markets, use new ways of organizing, incorporate new raw materials, or use new processes to meet customer needs. Certainly, information technology—the use of zeros and ones in digital form on computers—is an important technology, but there are many other important technologies as well. Biologically based technologies, such as those used to create new drugs or to clean up pollution, are also important. Similarly, mechanically based technologies, such as those that make pumps or valves, matter. New materials, such as those in new ceramic composites, are valuable.

Q: You say that high-technology ventures have a greater chance of success than low-technology ventures. Why is a high- technology business more likely to be successful than a low-technology business?

A: High-technology businesses are based on advances in technology—developments in materials, drugs, software, equipment—that make it possible to develop new products, design new production processes, create new ways of organizing, and target new markets to meet customer needs that could not previously be satisfied, or satisfy those needs in a way better than the competition. They also provide ways to capture the returns to entrepreneurship so the profits go to the entrepreneur, not imitators. This can be done much more easily in high technology than in low technology. And the numbers reflect that.

Q: Also, doesn't the mass of dot-com busts indicate that online ventures are just as risky or riskier than off-line ventures?

A: Even at the height of the dot-com bust, a smaller percentage of dot-com start-ups went under than the percentage of new restaurants or retail stores. So, no, dot-com ventures are less risky than typical retail businesses.

Q: You say that "if you start a biotechnology firm, your chances of success are much greater than if you start a restaurant." That seems absolutist. Aren't there situations that change that equation? For example, I live in a rural community that is booming with new home construction, bringing in hundreds of middle- to high-income families to the area. There are great opportunities for entrepreneurs in that area, because there is a huge demand that is not being met—including for restaurants.

A: To be successful, an entrepreneur needs to identify a need, find a way to satisfy that need and come up with a way to keep others from imitating the solution. The problem with restaurant businesses is twofold—first you might benefit from some local demand, but there are going to be limits to how large your business can be. If you develop a drug that cures heart disease, you have worldwide unmet demand that is very large. There is no world-wide unmet demand for your restaurant. Second, you can patent your drug, making it difficult for others to imitate you. But your restaurant can be imitated. If you see excess demand in your area, so will others. They, too, will start restaurants. The number of restaurants founded in your area will be proportional to this excess demand and, unless you have something that makes you better than the competition (perhaps your mother's secret recipes), you will not capture the profits.

These forces are what show up in the data. The average new restaurant's rate of becoming an INC 500 or IPO firm is about 1/265 that of the average biotech firm.

Back to Top
Back 1 of 3 Next
The Wharton School of the University of Pennsylvania Home | Archives | About Us | Connections

Copyright © 2002 The Wharton School of the University of Pennsylvania. All rights reserved.